Neoadjuvant chemoradiotherapy for pancreatic cancer is beneficial, but schedules should be improved
@article{DMR6388, author = {Geertjan van Tienhoven and Eva Versteijne and Marc G. Besselink and Johanna W. Wilmink and Anna M. Bruynzeel}, title = {Neoadjuvant chemoradiotherapy for pancreatic cancer is beneficial, but schedules should be improved}, journal = {Digestive Medicine Research}, volume = {3}, number = {0}, year = {2020}, keywords = {}, abstract = {}, issn = {2617-1627}, url = {https://dmr.amegroups.org/article/view/6388} }